alexa Boceprevir in Mexico

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Boceprevir in Mexico

There are many new drugs for HCV treatment. First generation protease inhibitors are about to be discontinued. However in developing countries the likelihood of access to these new drugs is vague. As in other poor countries, in Mexico we only have peg interferon and ribavirin for HCV treatment and the costs of the new therapies are hard to fill. This is a report of the outcome in 30 patients who received triple therapy adding Boceprevir to peg interferon and Ribavirin as part of an extended-access program. As described elsewhere Latinos have lower response rates. This is the largest series of cases in Mexico City, and we would like to share this experience with other developing countries.

 

Citation:Mata-Marín JA, Sandoval-Ramirez JL, Manjarrez-Tellez B, Gaytán-Martínez JE, Chaparro-Sánchez A (2015) Boceprevir in Mexico: Experience in a Series of Cases. J Gastrointest Dig Syst 5: 317. doi:10.4172/2161-069X.1000317

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords